QIAGEN PE Ratio 2010-2022 | QGEN
Current and historical p/e ratio for QIAGEN (QGEN) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. QIAGEN PE ratio as of March 20, 2023 is 19.46.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| QIAGEN PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2023-03-20 |
45.84 |
|
31.61 |
| 2022-12-31 |
49.87 |
$1.45 |
34.39 |
| 2022-09-30 |
41.28 |
$2.01 |
20.54 |
| 2022-06-30 |
47.20 |
$2.22 |
21.26 |
| 2022-03-31 |
49.00 |
$2.32 |
21.12 |
| 2021-12-31 |
55.58 |
$2.21 |
25.15 |
| 2021-09-30 |
51.68 |
$2.56 |
20.19 |
| 2021-06-30 |
48.38 |
$2.06 |
23.49 |
| 2021-03-31 |
48.69 |
$1.92 |
25.36 |
| 2020-12-31 |
52.85 |
$1.53 |
34.54 |
| 2020-09-30 |
52.26 |
$0.81 |
64.52 |
| 2020-06-30 |
42.81 |
$0.03 |
1427.00 |
| 2020-03-31 |
41.60 |
$-0.16 |
0.00 |
| 2019-12-31 |
33.80 |
$-0.20 |
0.00 |
| 2019-09-30 |
32.97 |
$-0.13 |
0.00 |
| 2019-06-30 |
40.55 |
$0.84 |
48.27 |
| 2019-03-31 |
40.68 |
$0.81 |
50.22 |
| 2018-12-31 |
34.45 |
$0.82 |
42.01 |
| 2018-09-30 |
37.88 |
$0.38 |
99.68 |
| 2018-06-30 |
36.16 |
$0.16 |
226.00 |
| 2018-03-31 |
32.31 |
$0.15 |
222.21 |
| 2017-12-31 |
30.93 |
$0.10 |
312.74 |
| 2016-12-31 |
29.10 |
$0.34 |
85.28 |
| 2016-09-30 |
28.50 |
$0.51 |
55.99 |
| 2016-06-30 |
22.65 |
$0.51 |
44.51 |
| 2016-03-31 |
23.20 |
$0.63 |
37.09 |
| 2015-12-31 |
28.71 |
$0.68 |
42.39 |
| 2015-09-30 |
26.81 |
$0.55 |
48.51 |
| 2017-09-30 |
31.50 |
$0.52 |
60.40 |
| 2015-06-30 |
25.74 |
$0.46 |
56.34 |
| 2015-03-31 |
26.17 |
$0.49 |
53.61 |
| 2014-12-31 |
24.36 |
$0.47 |
52.39 |
| 2014-09-30 |
23.65 |
$0.45 |
52.01 |
| 2014-06-30 |
25.39 |
$0.57 |
44.64 |
| 2017-06-30 |
33.53 |
$0.60 |
55.89 |
| 2014-03-31 |
21.90 |
$0.31 |
70.33 |
| 2013-12-31 |
24.73 |
$0.29 |
85.06 |
| 2013-09-30 |
22.22 |
$0.11 |
200.03 |
| 2013-06-30 |
20.68 |
$0.10 |
205.12 |
| 2013-03-31 |
21.89 |
$0.45 |
48.23 |
| 2017-03-31 |
28.97 |
$0.52 |
56.12 |
| 2012-12-31 |
18.85 |
$0.56 |
33.61 |
| 2012-09-30 |
19.22 |
$0.39 |
48.71 |
| 2012-06-30 |
17.34 |
$0.43 |
40.73 |
| 2012-03-31 |
16.17 |
$0.43 |
37.97 |
| 2011-12-31 |
14.34 |
$0.43 |
33.68 |
| 2011-09-30 |
14.36 |
$0.58 |
24.69 |
| 2011-06-30 |
19.75 |
$0.58 |
33.96 |
| 2011-03-31 |
20.82 |
$0.60 |
34.56 |
| 2010-12-31 |
20.30 |
$0.62 |
32.58 |
| 2010-09-30 |
18.42 |
$0.65 |
28.16 |
| 2010-06-30 |
19.96 |
$0.69 |
29.12 |
| 2010-03-31 |
23.87 |
$0.68 |
35.37 |
| 2009-12-31 |
23.19 |
$0.65 |
35.45 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$10.502B |
$2.142B |
|
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
|
